KUVAN

Sapropterin dihydrochloride · BioMarin Pharmaceutical Inc.

Drug timelines are a Plus or Pro feature.

42 regulatory and trial events tracked for KUVAN, covering 2007-12-13 to 2026-01-07. Get the full timeline:

Most recent: EMA Authorised: Kuvan (sapropterin dihydrochloride) — BioMarin International Limited